A novel P40-independent function of IL-12P35 is required for progression and maintenance of herpes stromal keratitis

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 7, 2010, Pages 3591-3598

  Frank, Gregory M ^a,b   Divito, Sherrie J ^a,b,c   Maker, Dawn M ^a   Xu, Min ^a   Hendricks, Robert L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; CYTOKINE; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 23; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P19; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL INFILTRATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; DISEASE COURSE; EPSTEIN BARR VIRUS INDUCED GENE 3; FEMALE; GENE; HERPES SIMPLEX VIRUS 1; HERPES STROMAL KERATITIS; KERATITIS; KNOCKOUT MOUSE; LEUKOCYTE; MOUSE; MOUSE STRAIN; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CORNEA STROMA; DISEASE MODEL; FLOW CYTOMETRY; HERPES SIMPLEX KERATITIS; IMMUNOLOGY; LYMPHOCYTE DEPLETION; METABOLISM; MOUSE MUTANT; NEUTROPHIL; PHYSIOLOGY; TH1 CELL; VIROLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CORNEAL STROMA; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 1, HUMAN; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; KERATITIS, HERPETIC; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHILS; TH1 CELLS;

EID: 77955868238     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4368     Document Type: Article

References (48)

1. Wolf SF, Temple PA, Kobayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991;146:3074-3081.
2. Heinzel FP, Rerko RM, Ahmed F, Pearlman E. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol. 1995; 155:730-739.
3. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715-725.
4. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Inter-leukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003; 278:1910-1914.
5. Ling P, Gately MK, Gubler U, et al. Human Il-12 P40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol. 1995;154:116-127.
6. Piccotti JR, Chan SY, Li KW, Eichwald EJ, Bishop DK. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4(+) and CD8(+) IFN-gamma-producing cells. J Immunol. 1997;158:643-648.
7. Khader SA, Partida-Sanchez S, Bell G, et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med. 2006;203: 1805-1815
8. Russell TD, Yan Q, Fan G, et al. IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1. J Immunol. 2003;171: 6866-6874.
9. Nieuwenhuis EE, Neurath MF, Corazza N, et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci USA. 2002;99:16951-16956.
10. Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450: 566-569.
11. Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity. 2002;16:779-790.
12. Hendricks RL, Tumpey TM. Concurrent regeneration of T lymphocytes and susceptibility to HSV-1 corneal stromal disease. Curr Eye Res. 1991;10:47-53
13. Mercadal CM, Bousley DM, Destephano D, Rouse B. Herpetic stromal keratitis in the reconstituted SCID mouse model. J Virol. 1993;67:3404-3408.
14. Metcalf JF, Hamilton DS, Reichert RW. Herpetic keratitis in athy-mic (nude) mice. Infect Immun. 1979;26:1164-1171.
15. Newell CK, Martin S, Sendele D, Mercadal CM, Rouse BT. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol. 1989;63:769-775
16. Tang Q, Hendricks RL. Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J Exp Med. 1996;184:1435-1447.
17. Stumpf TH, Shimeld C, Easty DL, Hill TJ. Cytokine production in a murine model of recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci. 2001;42:372-378.
18. Babu JS, Kanangat S, Rouse BT. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol. 1995;154:4822-4829.
19. Keadle TL, Usui N, Laycock KA, Kumano Y, Pepose JS, Stuart PM. Cytokine expression in murine corneas during recurrent herpetic stromal keratitis. Ocul Immunol Inflamm. 2001;9:193-205.
20. Keadle TL, Stuart PM. Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis. Microb Pathog. 2005;38:13-21.
21. Niemialtowski MG, Rouse BT. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol. 1992;149: 3035-3039.
22. Duan R, Remeijer L, van Dun JM, Osterhaus AD, Verjans GM. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Invest Ophthalmol Vis Sci. 2007;48:277-284.
23. Maertzdorf J, Osterhaus AD, Verjans GM. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J Immunol. 2002;169:5897-5903
24. Kanangat S, Thomas J, Gangappa S, Babu JS, Rouse BT. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression: implications in immunopathogenesis and protection. J Immunol. 1996;156:1110-1116.
25. Kumaraguru U, Rouse BT. The IL-12 response to herpes simplex virus is mainly a paracrine response of reactive inflammatory cells. JLeukoc Biol. 2002;72:564-570.
26. Al Khatib K, Campbell IL, Carr DJ. Resistance to ocular herpes simplex virus type 1 infection in IL-12 transgenic mice. J Neuro-immunol 2002;132:41-48.
27. Osorio Y, Wechsler SL, Nesburn AB, Ghiasi H. Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice. Virus Res. 2002;90:317-326.
28. Kim B, Sarangi PP, Azkur AK, Kaistha SD, Rouse BT. Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes Infect. 2008;10:302-312.
29. Liu T, Khanna KM, Chen X, Fink DJ, Hendricks RL. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med. 2000;191:1459-1466.
30. Lepisto AJ, Frank GM, Xu M, Stuart PM, Hendricks RL. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice. Invest Ophthalmol Vis Sci. 2006;47:3400-3409.
31. Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT. CD4+CD25+ regulatory T cells control the severity of viral im-munoinflammatory lesions.JImmunol. 2004;172:4123-4132.
32. Divito SJ, Hendricks RL. Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest Ophthalmol Vis Sci 2008;49:1488-1495
33. Lee SK, Choi BK, Kang WJ, et al. MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis. Mol Cells. 2008;26:67-73
34. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-238.
35. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGF/3 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179-189.
36. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-beta in human aqueous humor. Curr Eye Res. 1990;9:963-969.
37. Wilson SE, Schultz GS, Chegini N, Weng J, He YG. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res. 1994;59:63-71.
38. Thomas J, Kanangat S, Rouse BT. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J Interferon Cytokine Res. 1998;18:681-690.
39. Kim B, Sarangi PP, Lee Y, Deshpande KS, Lee S, Rouse BT. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. JLeukoc Biol. 2006;80:1405-1415
40. Tumpey TM, Cheng H, Cook DN, Smithies O, Oakes JE, Lausch RN. Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis.J Virol. 1998;72: 3705-3710.
41. Tumpey TM, Cheng H, Yan XT, Oakes JE, Lausch RN. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10.JLeukoc Biol. 1998;63:486-492.
42. Yan X-T, Tumpey TM, Kunkel SL, Oakes JE, Lausch RN. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci. 1998; 39:1854-1862.
43. Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol. 2001;75:9828-9835
44. Biswas PS, Banerjee K, Kinchington PR, Rouse BT. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res. 2006;82:46-54.
45. -/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol. 2004;172:1237-1245.
46. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996;271:736-741.
47. Fenton RR, Molesworth-Kenyon S, Oakes JE, Lausch RN. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest Ophthalmol Vis Sci. 2002;43:737-743
48. Gubler U, Chua AO, Schoenhaut DS, et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA. 1991;88: 4143-4147.